As of 2025-06-20, the Intrinsic Value of Dynavax Technologies Corp (DVAX) is 1.06 USD. This DVAX valuation is based on the model Discounted Cash Flows (EBITDA Exit 5Y). With the current market price of 10.30 USD, the upside of Dynavax Technologies Corp is -89.70%.
The range of the Intrinsic Value is 0.72 - 1.43 USD
Based on its market price of 10.30 USD and our intrinsic valuation, Dynavax Technologies Corp (DVAX) is overvalued by 89.70%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | (10.05) - (3.51) | (4.53) | -144.0% |
| DCF (Growth 10y) | (1.44) - 2.83 | (0.79) | -107.7% |
| DCF (EBITDA 5y) | 0.72 - 1.43 | 1.06 | -89.7% |
| DCF (EBITDA 10y) | 2.28 - 4.08 | 3.11 | -69.8% |
| Fair Value | -12.51 - -12.51 | -12.51 | -221.42% |
| P/E | (7.54) - 10.70 | 0.46 | -95.5% |
| EV/EBITDA | (1.01) - 3.81 | 0.62 | -94.0% |
| EPV | 7.66 - 11.61 | 9.63 | -6.5% |
| DDM - Stable | (5.94) - (32.26) | (19.10) | -285.4% |
| DDM - Multi | 7.64 - 32.80 | 12.46 | 20.9% |
| Market Cap (mil) | 1,236.82 |
| Beta | 0.45 |
| Outstanding shares (mil) | 120.08 |
| Enterprise Value (mil) | 1,445.61 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.65% |
| Cost of Debt | 5.50% |
| WACC | 7.29% |